1) Funk CD : Prostaglandins and leukotrienes : advances in eicosanoid biology. Science 294:1871-1875,2001
: biochemical properties and physiological roles. IUBMB Life 58:328-333,2006
3) Fenn JB, Mann M, Meng CK, et al : Electrospray ionization for mass spectrometry of large biomolecules. Science 246:64-71,1989
4) Kita Y, Takahashi T, Uozumi N, et al : Pathway-oriented profiling of lipid mediators in macrophages. Biochem Biophys Res Commun 330:898-906,2005
5) Kita Y, Takahashi T, Uozumi N, et al : A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. Anal Biochem 342:134-143,2005
6) Wang Q, Yu S, Simonyi A, et al : Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol 31:3-16,2005
7) Yoshikawa K, Kita Y, Kishimoto K, et al : Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure : dual phase regulation and differential involvement of COX-1 and COX-2.J Biol Chem 281:14663-14669,2006
8) Sharma AK, Searfoss GH, Reams RY, et al : Kainic acid-induced F-344 rat model of mesial temporal lobe epilepsy : gene expression and canonical pathways. Toxicol Pathol 37:776-789,2009
9) Baker D, Gerritsen W, Rundle J, et al : Critical appraisal of animal models of multiple sclerosis. Mult Scler 17:647-657,2011
10) Kihara Y, Matsushita T, Kita Y, et al : Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis. Proc Natl Acad Sci USA 106:21807-21812,2009
11) Vogeser M, Seger C : Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem 56:1234-1244,2010